Gemcitabine Resistance of Pancreatic Cancer Cells Is Mediated by IGF1R Dependent Upregulation of CD44 Expression and Isoform Switching

CD44 promoter activity and its interactive EMT-related transcription factors were evaluated by luciferase reporter assay and chromatin immunoprecipitation assay.